Infineon Joins Fight against AIDS and Becomes Member of the Global Business Coalition on HIV/AIDS Business Wire
click here to return to Business Wire main menu
DonateNow
Print this Article


Infineon Joins Fight against AIDS and Becomes Member of the Global Business Coalition on HIV/AIDS

Business Wire - December 19, 2003

MUNICH, Germany -- Infineon Technologies, the world's sixth-largest semiconductor company, is the first semiconductor manufacturer to join the Global Business Coalition on HIV/AIDS (GBC). The coalition, founded in 1997 and based in New York, is committed to increasing the role of business in supporting international efforts to extend the availability of AIDS treatment in developing countries. In addition, the business sector is now developing HIV/AIDS workplace programs, providing workers and their families with access to HIV prevention, testing, education and care. GBC is financed solely from fees and donations by its members. It currently brings together around 130 international companies on a private-public partnership basis and operates mainly in Africa and the recently affected countries of Eastern Europe, in the Russian Federation and in Asia. The GBC members deploy their marketing and communications expertise and logistical skills in regions affected by HIV with the aim of raising awareness about AIDS and supporting education programs. Campaigns launched at member company locations educate employee about the dangers of the disease and about infection routes. Beyond the boundaries of their own premises, the members also run programs to expand the member base. Jurgen Schrempp, Chairman and CEO of DaimlerChrysler, has been Chairman of the GBC since 2002.

"By joining the Global Business Coalition on HIV/AIDS we want to assume the socio-political responsibility to enlist in the fight against AIDS and will support the organization in its information and prevention activities in our regions", declared Dr. Ulrich Schumacher, President and CEO of Infineon Technologies. Infineon will also take part in recruiting new GBC members in Asia, particularly in China and India, where the GBC has only been poorly represented to date. Currently, 42 million people worldwide are infected with the HIV virus. You can find further information about the GBC at www.businessfightsaids.org

About Infineon

Infineon Technologies AG, Munich, Germany, offers semiconductor and system solutions for the automotive and industrial sectors, for applications in the wired communications markets, secure mobile solutions as well as memory products. With a global presence, Infineon operates in the US from San Jose, CA, in the Asia-Pacific region from Singapore and in Japan from Tokyo. In fiscal year 2003 (ending September), the company achieved sales of Euro 6.15 billion with about 32,300 employees world- wide. Infineon is listed on the DAX index of the Frankfurt Stock Exchange and on the New York Stock Exchange. Further information is available at www.infineon.com.

This news release is available online at http://www.infineon.com/news/

General video material can be downloaded from www.thenewsmarket.com.

CONTACT: Infineon Technologies

Corporate Communications/

Worldwide Headquarters

Barbara Reif

Phone / Fax: +49 89 234 20166 / 28482

barbara.reif@infineon.com

or

U.S.A.

Christoph Liedtke

Phone / Fax: +1 408 501 6790 / 2424

christoph.liedtke@infineon.com

or

Asia

Kaye Lim

Phone / Fax: +65 6840 0689 / 0073

kaye.lim@infineon.com

or

Japan

Hirotaka Shiroguchi

Phone / Fax: +81 3 5449 6795 / 6401

hirotaka.shiroguchi@infineon.com

or

Investor Relations

EU/APAC +49 89 234 26655

USA/CAN +1 408 501 6800

investor.relations@infineon.com

SOURCE: Infineon Technologies


031219
BW031207

Copyright © 2003 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .